Skip to main content

Global
Regions
WHO Regional websites
Countries
- Albania
- Andorra
- Armenia
- Austria
- Azerbaijan
- Belarus
- Belgium
- Bosnia and Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czechia
- Denmark
- Estonia
- Finland
- France
- Georgia
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Israel
- Italy
- Kazakhstan
- Kyrgyzstan
- Latvia
- Lithuania
- Luxembourg
- Malta
- Monaco
- Montenegro
- Netherlands (Kingdom of the)
- North Macedonia
- Norway
- Poland
- Portugal
- Republic of Moldova
- Romania
- Russian Federation
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Tajikistan
- Türkiye
- Turkmenistan
- Ukraine
- United Kingdom of Great Britain and Northern Ireland
- Uzbekistan

When autocomplete results are available use up and down arrows to review and enter to select.

Select language

Home

Health topics

All topics
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Resources

Popular

Our work

Our work

Policies

Flagship initiatives

Core priorities

Newsroom

Newsroom

Headlines

Data

Data at WHO/Europe

Highlights
- News
- Events
- Publications

About us

The European Health Report 2024

Emergencies

Focus on

Our work in emergencies

Health emergencies in the Region
- Health emergencies list

Ukraine emergency

About us

About WHO Europe

Governance
- Regional Committee for Europe
- Standing Committee

Partnerships

Second European Programme of Work

Home
Multimedia
item
Models for financing novel medicines to support innovation as a global public good

Models for financing novel medicines to support innovation as a global public good

13 February 2022

| video (webinar)

WHO Team

Access to Medicines and Health Products (AMD), Division of Health Systems (DHS)

Quick links
- Media centre
- Emergencies
About us
Help

Subscribe to our newsletters

Privacy Legal Notice

© 2026